Researchers at the University of Calgary have developed a new immunotherapy that is being used to treat solid cancerous tumours. The treatment has shown promise in reducing rare cancerous tumours, although its effectiveness for other types of cancer is not clear. It is one of several immunotherapy developments being explored, with other institutions also working on similar treatments for various types of cancer, including brain and colon cancer.